108 related articles for article (PubMed ID: 215531)
1. General immunological status of nasopharyngeal carcinoma patients in Singapore.
Chan SH; Goh EH; Khor TH; Chew TS
IARC Sci Publ (1971); 1978; (20):495-501. PubMed ID: 215531
[TBL] [Abstract][Full Text] [Related]
2. Effect of levamisole on cell-mediated immune responses in patients with nasopharyngeal carcinoma.
Goh EH; Chan SH; Simons MJ
IARC Sci Publ (1971); 1978; (20):503-10. PubMed ID: 730200
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity, Epstein-Barr virus and nasopharyngeal carcinoma.
Levine PH; Lamelin JP; Stevens DA
IARC Sci Publ (1971); 1978; (20):483-94. PubMed ID: 215530
[TBL] [Abstract][Full Text] [Related]
4. Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma.
Sawaki S; Kawamura A; Tachibana T
IARC Sci Publ (1971); 1978; (20):575-85. PubMed ID: 215534
[TBL] [Abstract][Full Text] [Related]
5. Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma.
Chan SH; Chew TS; Goh EH; Simons MJ; Shanmugaratnam K
Int J Cancer; 1976 Aug; 18(2):139-44. PubMed ID: 955740
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.
Whitney BM; Chan AT; Rickinson AB; Lee SP; Lin CK; Johnson PJ
J Med Virol; 2002 Jul; 67(3):359-63. PubMed ID: 12116028
[TBL] [Abstract][Full Text] [Related]
7. Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma.
Galili U; Klein E; Klein G; Singh Bal I
Int J Cancer; 1980 Jan; 25(1):85-9. PubMed ID: 6249765
[TBL] [Abstract][Full Text] [Related]
8. In vivo cell-mediated immunity in Chinese patients with nasopharyngeal carcinoma.
Ho JH; Chau JC; Tse KC; Ng MH; Levine PH
IARC Sci Publ (1971); 1978; (20):545-52. PubMed ID: 215533
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal carcinoma and histocompatibility antigens.
Simons MJ; Chan SH; Wee GB; Shanmugaratnam K; Goh EH; Ho JH; Chau JC; Darmalingam S; Prasad U; Betuel H; Day NE; de-The G
IARC Sci Publ (1971); 1978; (20):271-82. PubMed ID: 730194
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
[TBL] [Abstract][Full Text] [Related]
11. [Immunovirological factors in epitheliomas of the rhinopharynx].
de-Thé G
Bull Cancer; 1975; 62(3):265-76. PubMed ID: 172172
[TBL] [Abstract][Full Text] [Related]
12. Immunologic study on nasopharyngeal carcinoma patients: correlation of in vivo and in vitro reactivity to phytohemagglutinin.
Hsu MM; Lo P
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Feb; 16(1):20-32. PubMed ID: 6851721
[TBL] [Abstract][Full Text] [Related]
13. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
Mazeron MC
Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of HLA class II antigens on EBV positive malignant cells from nasopharyngeal carcinoma: possible involvement in T cell infiltration.
Busson P; Braham K; Clausse B; Tursz T
Cancer Detect Prev; 1988; 12(1-6):363-8. PubMed ID: 2846171
[TBL] [Abstract][Full Text] [Related]
15. Combined transfection with EBV-specific epitopes and HLA-A2 genes is more effective than separate transfection in promoting CTL lysis against nasopharyngeal carcinoma.
Ding W; Fong C
Cell Mol Immunol; 2004 Jun; 1(3):229-34. PubMed ID: 16219173
[TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview.
Neel HB
J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165
[TBL] [Abstract][Full Text] [Related]
17. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
Sansoni P; Rossetti A; Valente G; Butturini U
Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
[No Abstract] [Full Text] [Related]
18. Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies.
Jondal M; Klein G
Biomedicine; 1975 Jun; 23(5):163-5. PubMed ID: 1081410
[TBL] [Abstract][Full Text] [Related]
19. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test].
Micheau C; De The G; Schwaab G; Tursz T; Sancho-Garnier H; Montagu B
Ann Pathol; 1984; 4(2):143-6. PubMed ID: 6329239
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunity in nasopharyngeal carcinoma. III. Lymphocyte subpopulations and lymphocyte response to phytohemagglutinin.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Tu SM
Taiwan Yi Xue Hui Za Zhi; 1978 Jul; 77(7):549-55. PubMed ID: 308994
[No Abstract] [Full Text] [Related]
[Next] [New Search]